Published in Mol Cell Biol on September 01, 1996
Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev (2000) 3.74
Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell (1998) 2.93
Anchorage-dependent cell cycle progression. J Cell Biol (1997) 2.09
Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell (2001) 1.75
Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol (2001) 1.69
Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest (1997) 1.47
Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J Cell Biol (1999) 1.29
Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. Mol Cell Biol (2006) 1.20
p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma. J Clin Invest (1999) 1.19
Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am J Pathol (1998) 1.19
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol (2000) 1.16
Dual stimulation of Ras/mitogen-activated protein kinase and RhoA by cell adhesion to fibronectin supports growth factor-stimulated cell cycle progression. J Cell Biol (2000) 1.14
Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth. Mol Cell Biol (1998) 1.05
Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression. Mol Cell Biol (1997) 1.01
Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest (1998) 0.93
Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J Virol (1998) 0.93
Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol (2001) 0.91
Distinct effects of mitogens and the actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity. Mol Cell Biol (2001) 0.91
The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J Clin Invest (1996) 0.88
Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation. J Biol Chem (2012) 0.85
Rho-associated kinase connects a cell cycle-controlling anchorage signal to the mammalian target of rapamycin pathway. J Biol Chem (2011) 0.85
Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival. Mol Biol Cell (2008) 0.83
Loss of cellular adhesion to matrix induces p53-independent expression of PTEN tumor suppressor. BMC Mol Biol (2002) 0.78
MAPK uncouples cell cycle progression from cell spreading and cytoskeletal organization in cycling cells. Cell Mol Life Sci (2012) 0.77
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
Integrins and signal transduction pathways: the road taken. Science (1995) 10.71
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 9.25
Mammalian G1 cyclins. Cell (1993) 9.04
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell (1994) 8.90
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev (1994) 8.52
Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev (1993) 8.03
Cyclin A is required at two points in the human cell cycle. EMBO J (1992) 7.96
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev (1993) 7.41
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40
D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol (1994) 7.35
Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (1990) 7.34
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell (1994) 7.05
Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc Natl Acad Sci U S A (1975) 6.59
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol (1995) 6.41
Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol (1995) 6.26
Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell (1991) 5.98
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev (1992) 5.73
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (1994) 5.12
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell (1991) 4.88
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (1990) 4.10
Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell (1994) 4.01
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell (1994) 3.74
Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci (1993) 3.48
Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell (1993) 3.42
DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci (1994) 3.32
Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science (1990) 3.19
A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (1993) 2.96
Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A (1994) 2.87
Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A (1994) 2.69
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun (1992) 2.55
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A (1992) 2.43
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science (1992) 2.41
Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science (1996) 2.38
Association of cdk2 kinase with the transcription factor E2F during S phase. Science (1992) 2.37
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev (1995) 2.33
Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol Biol Cell (1996) 2.12
A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A (1994) 1.95
Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol (1994) 1.88
An intron within the 16S ribosomal RNA gene of the archaeon Pyrobaculum aerophilum. Proc Natl Acad Sci U S A (1993) 1.72
Transcriptional repression by the Rb-related protein p107. Mol Biol Cell (1993) 1.72
Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. Bioessays (1989) 1.62
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol (1995) 1.52
Arrest of 3T3 cells in G1 phase in suspension culture. J Cell Physiol (1975) 1.37
Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J (1996) 1.37
Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene (1995) 1.34
G1/S control of anchorage-independent growth in the fibroblast cell cycle. J Cell Biol (1991) 1.33
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-beta 1 control G1/S transit specifically. J Cell Biol (1993) 1.16
Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene (1995) 1.08
Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol (1995) 1.05
The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene (1995) 0.96
An anchorage-dependent locus in the cell cycle for the growth of 3T3 cells. Exp Cell Res (1981) 0.95
Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene (1994) 0.94
Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation. J Cell Biochem (1996) 0.92
Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma. Diagn Mol Pathol (1994) 0.85
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (1990) 4.10
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (1990) 2.61
Cyclin A is required in S phase in normal epithelial cells. Biochem Biophys Res Commun (1992) 2.55
B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J (1995) 2.51
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Association of cdk2 kinase with the transcription factor E2F during S phase. Science (1992) 2.37
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol (1994) 2.11
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10
Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J Biol Chem (1999) 2.00
Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol (1996) 1.97
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci U S A (1999) 1.93
Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene (1996) 1.83
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J (1985) 1.76
Diseases of aging. Vaccine (2000) 1.53
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol (1995) 1.52
Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene (1992) 1.46
Differential expression and cellular distribution of centrin isoforms during human ciliated cell differentiation in vitro. J Cell Sci (2000) 1.45
p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol (1997) 1.37
Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J (1996) 1.37
Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene (2001) 1.36
Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol (2001) 1.34
Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol Cell Biol (1996) 1.33
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol (1994) 1.30
E2F target genes and cell-cycle checkpoint control. Bioessays (1999) 1.30
High-resolution respirometry--a modern tool in aging research. Exp Gerontol (2005) 1.27
Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res (2000) 1.19
Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Biochem J (2001) 1.16
c-myc and immunoglobulin kappa light chain constant genes are on the 8q+ chromosome of three Burkitt lymphoma lines with t(2;8) translocations. EMBO J (1984) 1.12
Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer (1999) 1.11
Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene (1992) 1.10
Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp Gerontol (2006) 1.08
Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A (1989) 1.07
Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet (1992) 1.05
Cation- and peptide-binding properties of human centrin 2. FEBS Lett (2000) 1.04
Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. Cancer Res (1992) 1.02
Allosteric activation of acid alpha-glucosidase by the human papillomavirus E7 protein. J Biol Chem (2000) 1.00
Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol (2000) 1.00
Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. J Exp Med (2001) 0.97
Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene. Oncogene (2001) 0.96
Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene (1994) 0.94
TGF-beta 1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene (1995) 0.94
Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J Virol (1998) 0.93
Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein. Oncogene (1996) 0.93
Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity. Mol Cell Biol (1999) 0.92
Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Differ (1997) 0.92
Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107. J Virol (1996) 0.91
A pollen model in the rat for testing adjuvant activity of air pollution components. Inhal Toxicol (1999) 0.91
Loss of the G1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts. Cell Growth Differ (1993) 0.90
S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase. Oncogene (1996) 0.89
Metabolic stabilization of p27 in senescent fibroblasts correlates with reduced expression of the F-box protein Skp2. Exp Gerontol (2001) 0.88
Activation of cyclin A gene expression by the cyclin encoded by human herpesvirus-8. J Gen Virol (1999) 0.87
The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes. Oncogene (1995) 0.86
Histone deacetylases in replicative senescence: evidence for a senescence-specific form of HDAC-2. FEBS Lett (2001) 0.84
Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis. Arch Otolaryngol (1976) 0.81
Theoretical study of the complexation of amphotericin B with sterols. Biochim Biophys Acta (1994) 0.81
The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53. FEBS Lett (2000) 0.80
Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7. J Gen Virol (1995) 0.80
Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood (1988) 0.78
[Alpha 2 macroglobulin immunoturbidimetric assays (DakoCytomation reagents) on Roche Diagnostic analysers (Modular P, Cobas Integra). Application to FibroTest-Actic-Test]. Ann Biol Clin (Paris) (2005) 0.78
Comparative theoretical study of the conformations of amphotericin methyl ester and amphotericin B polar heads in the presence of water. Biochim Biophys Acta (1992) 0.78
Assignment of a human cyclin A gene to 4q26-q27. Genomics (1990) 0.78
Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein. J Gen Virol (1999) 0.77
Replicative senescence of human primary cells--molecules and mechanisms. Exp Gerontol (2000) 0.77
Enumeration of alphafetoprotein secreting cells using a reverse hemolytic plaque assay during the growth of Morris hepatoma 7777 in culture. Biochem Biophys Res Commun (1977) 0.76
[Dyspraxic children, figurative and semeiotic aspects]. Neuropsychiatr Enfance Adolesc (1982) 0.75
[On signs of instability in neurological examination of children]. Arch Psicol Neurol Psichiatr (1970) 0.75
Burkitt's lymphoma variant translocations: distribution of chromosomal breakpoints and perturbated regulation of a mutated c-myc gene. Curr Top Microbiol Immunol (1988) 0.75
Neurological findings associated with spatial disorders in children. Perception (1972) 0.75
[Cognitive disharmony and dyscalculia]. Rev Neuropsychiatr Infant (1973) 0.75
[Dyspraxia in children 5 to 15 years old. Diagnosis. Procedure to follow]. Rev Neuropsychiatr Infant (1966) 0.75
[Study on laterality. II. The problem of pathologic laterality]. Rev Neuropsychiatr Infant (1968) 0.75
[Methods of approach for the study of motor function in children]. Rev Neuropsychiatr Infant (1967) 0.75
Neurological evaluation of the premature infant. A follow-up study. Biol Neonate (1970) 0.75
[Place of nortriptyline in the group of antidepressants; clinical and electroencephalographic considerations]. Ann Med Psychol (Paris) (1967) 0.75
t(2;8) variant translocation in Burkitt's lymphoma: mapping of chromosomal breakpoints by in situ hybridization. Int J Cancer (1989) 0.75
[Motoricity and psychomotoricity]. Rev Neuropsychiatr Infant (1966) 0.75
[The delayed syndrome of the premature. Research on its significance]. Rev Neuropsychiatr Infant (1969) 0.75
[Attempt at the individualization of the body axis syndrome in child functional neurology]. Rev Neuropsychiatr Infant (1976) 0.75
[Blood cell count and seasonal diseases: leukocytosis in 50 persons in contact with benzenic hydrocarbons from 1964 to 1971]. Arch Mal Prof (1973) 0.75